Investing.com - AC Immune (NASDAQ: ACIU) reported first quarter EPS of CHF-0.060, CHF0.04 better than the analyst estimate of CHF-0.099. Revenue for the quarter came in at CHF15.05M versus the consensus estimate of CHF35.05M.
AC Immune's stock price closed at CHF3.700. It is down -5.610% in the last 3 months and up 51.300% in the last 12 months.
AC Immune saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See AC Immune's stock price’s past reactions to earnings here.
According to InvestingPro, AC Immune's Financial Health score is "fair performance".
Check out AC Immune's recent earnings performance, and AC Immune's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar